The groundbreaking treatment of the medication represents a significant breakthrough in the management of type 2 diabetes. Distinct from existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 https://tirzepatide-peptide016902.activosblog.com/40543930/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment